Stroke survivors may lose month of healthy life for 15-minute delay in treatment
American Heart Association Rapid Access Journal Report
- Every 15-minute delay in delivering a clot-busting drug after stroke robs survivors of an average month of healthy life.
- Streamlining the time from symptom onset to clot-busting treatment by just one minute means one less day of disability for a survivor.
- While all stroke patients benefit from faster treatment, younger patients seem to gain more benefit than older patients.
Embargoed until 3 p.m. CT/4 p.m. ET Thursday, March 13, 2014.
While all stroke patients benefit from faster treatment, younger patients seem to gain more benefit than older patients
DALLAS, March 13, 2014 — Every 15-minute delay in delivering a clot-busting drug after stroke robs survivors of about a month of disability-free life, according to a new study in the American Heart Association journal Stroke.
On the other hand, speeding treatment by just one minute means another 1.8 days of healthy life, researchers said.
“‘Save a minute; save a day’ is the message from our study, which examined how even small reductions in treatment delays might benefit patients measurably in the long run,” said Atte Meretoja, M.D., Ph.D., M.Sc., lead author of the study and associate professor of neurology at the University of Melbourne in Australia.
“Clot-busting treatment works equally well, irrespective of race, ethnicity or gender,” Meretoja said. “Speedy restoration of blood flow to the brain is crucial for brain cell survival everywhere.”
The world’s fastest stroke services in Helsinki, Finland and Melbourne, Australia, take an average 20 minutes from hospital arrival to start of treatment, he said. Most American, Australian and European centers take 70-80 minutes.
“In this study, we wanted to quantify the importance of speed in the hope that concrete easy-to-relate-to figures will inspire medical services to measure and improve their game for the benefit of our stroke patients,” Meretoja said.
Meretoja and colleagues used evidence from the combined major clot-busting trials reported to date. They applied those findings to 2,258 consecutive stroke patients from Australia and Finland to calculate what the patient outcomes would have been if they had been treated faster or slower.
- For every minute the treatment could be delivered faster, patients gained an average 1.8 days of extra healthy life.
- Although all patients benefited from faster treatment, younger patients with longer life expectancies gained a little more than older patients.
“In stroke treatment, every minute saved gives patients days of healthy life,” Meretoja said. “Patients should never wait a single minute for stroke signs, such as face droop, arm weakness or speech disturbance, to go away. They should call for help immediately. Additionally, most emergency medical services and hospitals have the ability to reduce response and treatment delays significantly, and we have described how to do this.”
The study’s findings are generalizable to the U.S. population, he said.
F.A.S.T. is an easy way to remember the sudden signs of stroke. When you spot the signs, call 9-1-1 for help right away.
Co-authors are Mahsa Keshtkaran, M.Sc., Jeffrey L Saver, M.D.; Turgut Tatlisumak, M.D.; Mark W Parsons, M.D.; Markku Kaste, M.D.; Stephen M Davis, M.D.; Geoffrey A Donnan, M.D.; and Leonid Churilov, Ph.D. Author disclosures are on the manuscript.
The Australian National Health and Medical Research Council funded the study.
Infographic available on the right column of the release link http://newsroom.heart.org/news/stroke-survivors-may-lose-month-of-healthy-life-for-15-minute-delay-in-treatment?preview=3aec31c52b43684530921c1894563a6e
Learn how hospitals using the American Heart Association/American Stroke Association’s quality improvement initiative Target: Stroke dramatically improved their stroke treatment times. Find a Target: Stroke Honor Roll hospital near you.
For the latest heart and stroke news, follow @HeartNews on Twitter.
For stroke science, follow the Stroke journal at @StrokeAHA_ASA.
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.